Percutaneous Cryoablation of Clinical T1b Renal Tumors: A Tertiary Cancer Center Experience
CA (with and without embolization) is safe and effective in patients with clinical T1b RCC who are not candidates for surgery. Cryoablation offers durable local oncologic control and favorable long-term survival outcomes in appropriately selected patients.
Authors
- Francis Kang
- Stephen R. Lee (ORCID: https://orcid.org/0000-0002-6454-2226)
- Zeyad Ahmed Metwalli (ORCID: https://orcid.org/0000-0003-0067-5115)
- David Irwin (ORCID: https://orcid.org/0000-0002-5380-7137)
- Thomas Lu
- Jose A. Karam
- Bruno C. Odisio
- Mohamed A. Abdelsalam
- Ahmed Awad
- Kamran Ahrar
- Surena F. Matin
- Peiman Habibollahi
- Zhongya Wang
Institutions
- The University of Texas MD Anderson Cancer Center (US)
Publication Details
- Journal
- CardioVascular and Interventional Radiology
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1007/s00270-026-04381-y
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00